Generation Z is changing the face of healthcare from every angle. As patients, this generation prioritizes communication, access and convenience over privacy and wants flexible ways to connect with their healthcare providers. As employees, they are ambitious and bring more diversity and technical knowledge to healthcare organizations. Also, as key opinion leaders, they are adept at using social media and other digital channels to bring findings and evidence to attentive audiences to influence better outcomes.

Innately tolerant, diverse, socially conscious and digitally savvy, this generation of scientists will change the future of research forever. In fact, by 2030, 74% of his American workforce will be made up of millennials and her Gen Z. This segment will focus on the medical operations team, the definition and involvement of KOLs (Key Opinion Leaders), how clinical trials are conducted, and how treatments come to market – all for a more equitable future in healthcare. Hope to connect.

Generation Z wants to be the generation that ultimately achieves equality for all. Gen Z MSLs (Medical Science Liaisons) can be change agents by promoting diversity, inclusion and equity in all aspects of the healthcare lifecycle.

Generation Z MSLs

Generation Z, defined as those born between 1997 and 2012, will make up about 30% of the workforce by 2025.

Generation Z grew up in the digital age. Access to information, social media, and technology often comes as second nature, especially with trends and tools like analytics, AI, and machine learning. This generation is used to collaborating in virtual environments, and his MSL for Gen Z interacts differently with doctors. They don’t feel the need for face-to-face relationships. Picking up the phone is a thing of the past, and his MSL of Gen Z is more likely to communicate via text or other digital channels. How data is accessed and used is also different. This is why so many pharmaceutical and healthcare companies are investing in digital platforms to source new and emerging thought leaders.

Nearly 60% of all medical science liaisons are now Caucasian, and 49% are 40 years of age or older.

Arthur Chan, Vice President of Medical Affairs at Tarsus Pharmaceuticals, recently wrote an article about the importance of diversity in medical affairs. The industry is on board and taking steps to further this effort. For example, the Medical Science Liaison Society recently launched a diversity and inclusion initiative for the MSL community.

Gen Z also has a different perspective on diversity compared to their more experienced peers.As world economic forum “Older generations tend to see diversity through the lens of race, demographics, equality and representation, [the new generation sees] Diversity as an amalgamation of different experiences, different backgrounds and individual perspectives. They see the ideal workplace as a supportive environment that allows room for different perspectives on a particular issue. “

It’s also important for Gen Z to work for a company with sound principles and aspirations to make the world a better place. This generation often cares more about a company’s culture and its impact on the community than things like compensation. Racial equality is a key issue for this generation, and recent research shows they prioritize gender equality more than any other age group.

Generation Z MSLs Redefine KOLs

Pharmaceutical companies seek out KOLs with expertise and experience in specific therapeutic areas and engage physician peers on data interpretation, patient recruitment for clinical trials, and treatment regimens and which patient populations will benefit most. Provides support in teaching.

The problem is that medical practice tends to target only “top” academic medical centers and KOLs, and these professionals often do not reflect the actual patient and physician demographics, and lack a broader perspective. is. This leads to underrepresentation across the healthcare lifecycle, from biased clinical trials to inequitable treatment distributions. This is a vicious cycle, but his MSL of Gen Z is trying to fix it.

call out: almost 78% People of color are underrepresented in clinical trials. Generation Z could ultimately be the catalyst for change that will reverse these troubling statistics.

As medical affairs teams themselves become younger and more diverse, they will leverage technology to reinvent the way they define, discover and engage key thought leaders. Gone are the days when a handful of frequently published professionals were considered the top voice in healthcare. A new class of thought leaders and influencers has emerged amidst the industry’s rapid digital transformation. Similar to the Kardashian-like effect in consumer brands, Digital Opinion Leaders (DOLs), rising stars and yet-to-be-developed “untapped gems” have significantly increased the visibility of clinical trials and improved patient outcomes and health. can have a positive impact on the fairness of These KOLs are the primary treatment for a previously underserved patient population and are familiar with a digital medium not traditionally used in the industry. They have the potential to be the next big influencer and his MSL of Gen Z has the tools and knowledge to find them.

call out: A new class of experts (digital opinion leaders, rising stars, uncut gems) will emerge as Gen Z MSLs leverage technology to find and connect with these KOLs digitally.

While these experts may seem difficult to identify, their opinions may be as close as the Twitter feeds of Gen Z MSLs. Leverage digital channels to discover tomorrow’s thought leaders and connect with these modern experts to accelerate research and therapy. The new MSL incorporates social listening and sentiment tools to help you find the most influential and diverse DOLs (i.e., 400 people across 12 different therapeutic areas based on reach and social impact). DOL was discovered using the leading digital HCP platform).

They prefer using an intuitive platform that mimics what they use in their daily lives, using up-to-date KOL profiles with social content to gain insight into these experts and their sphere of influence. I can. And given that 75% of the U.S. workforce will be digital natives by 2025, using digital platforms for him to collaborate with HCPs and key thought leaders will soon become the norm.

Gen Z is the most diverse and digitally savvy generation ever. His MSL, Gen Z, uses technology to redefine what his KOLs are, how they are involved, and, ultimately, how clinical trials are conducted. have the skills and power to change the future of